Investors
Atlas Venture
Atlas Venture is a leading early-stage international venture capital firm that invests in technology and life sciences businesses in the U.S., Europe and Asia. Since inception in 1980, its partners have helped build over 300 companies in more than 15 different countries. Since 1990, 44 portfolio companies have been acquired and 40 are now public companies with an aggregate market capitalization of over $12 billion. Atlas Venture is currently investing from its seventh fund and manages over $2.5 billion in capital through offices in Boston, London, Munich and Paris. Atlas Venture's life sciences team has been an early investor in close to 100 biotechnology, pharmaceutical and medical device companies. The active portfolio comprises approximately 35 life sciences companies today and several new investments are made each year, from seed stage to pre-IPO stage. Atlas Venture's past life sciences investments include companies such as Actelion Pharmaceuticals (SWX: ATLN); Alnylam Pharmaceuticals (NASDAQ: ALNY); Crucell (NASDAQ: CRXL); deCODE genetics (NASDAQ: DCGN); Exelixis (NASDAQ: EXEL); Momenta (NASDAQ: MNTA) and Renovo (LSE: RNVO). For more information, visit www.atlasventure.com.
Third Rock Ventures
Third Rock Ventures L.L.C. is a premier venture firm focused on life sciences investing and launching companies that make a difference in people’s lives. The firm raised its first fund of $378 million in 2007. Collaborating with entrepreneurs, the Third Rock team applies its deep expertise to establish the roadmap and building blocks for rapidly growing and highly successful life sciences companies. The Third Rock team has a unique vision and experience in building great companies, extensive academic and industry networks and a collective track record for creatively managing the value creation path to deliver exceptional performance. For more information, please visit www.thirdrockventures.com.
GreatPoint Ventures
GreatPoint Ventures is a specialized investment firm, which focuses on seed stage commercialization of exciting new technologies. GreatPoint invests in "big picture" opportunities that have the potential to lead innovation and transform markets. They have been active across a broad spectrum of investment sectors, including energy, biotech, telecom, materials science, and semiconductor engineering and believe that their "market first" investment philosophy holds true across industries. For more information, please visit www.greatpointventures.com
